SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950144-05-002602
Filing Date
2005-03-16
Accepted
2005-03-16 13:06:10
Documents
12
Period of Report
2004-12-31

Document Format Files

Seq Description Document Type Size
1 NOVEN PHARMACEUTICALS, INC. g93790e10vk.htm 10-K 949607
2 LETTER AGREEMENT g93790exv10w36.htm EX-10.36 5945
3 INDUSTRIAL LONG-TERM LEASE g93790exv10w37.txt EX-10.37 111785
4 COMPUTATION OF EARNINGS PER SHARE g93790exv11.htm EX-11 11354
5 SUBSIDIARIES g93790exv21.htm EX-21 1236
6 CONSENT OF DELOITTE & TOUCHE LLP g93790exv23w1.htm EX-23.1 1440
7 CONSENT OF PRICEWATERHOUSECOOPERS g93790exv23w2.htm EX-23.2 1107
8 SECTION 302 CERTIFICATION OF CEO g93790exv31w1.htm EX-31.1 5634
9 SECTION 302 CERTIFICATION OF CFO g93790exv31w2.htm EX-31.2 5593
10 SECTION 906 CERTIFICATION OF CEO g93790exv32w1.htm EX-32.1 3414
11 SECTION 906 CERTIFICATION OF CFO g93790exv32w2.htm EX-32.2 3112
12 GRAPHIC g93790g9379000.gif GRAPHIC 1759
  Complete submission text file 0000950144-05-002602.txt   1104946
Mailing Address 11960 SW 144TH STREET MIAMI FL 33185
Business Address 11960 SW 144TH ST MIAMI FL 33186 3052535099
NOVEN PHARMACEUTICALS INC (Filer) CIK: 0000815838 (see all company filings)

IRS No.: 592767632 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-17254 | Film No.: 05684370
SIC: 2834 Pharmaceutical Preparations